Aethlon Medical
AEMD
7 hedge funds and large institutions have $45.6K invested in Aethlon Medical in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 9 closing their positions.
0.06% less ownership
Funds ownership: 0.4% → 0.34% (-0.06%)
50% less funds holding
Funds holding: 14 → 7 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
88% less capital invested
Capital invested by funds: $389K → $45.6K (-$344K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$9.51K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$97K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$71.2K |
| 3 |
Renaissance Technologies
New York
|
-$34.4K |
| 4 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$19.5K |
| 5 |
Two Sigma Investments
New York
|
-$15.2K |
AEMD Hedge Fund Activity: Q4 2025 in Review
7 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2025, worth a combined $45.6K — down 88% from $389K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AEMD and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $9.51K. The largest seller was HRT Financial, exiting entirely with an estimated $97K sold.
- 7 institutional investors held Aethlon Medical (AEMD) as of Q4 2025, down from 14 in Q3 2025.
- Funds reported $45.6K of Aethlon Medical stock for Q4 2025, down 88% quarter-over-quarter.
- 2 funds opened new Aethlon Medical positions in Q4 2025 and 9 closed out, a net change of -7 holders.
- The largest Aethlon Medical buyer in Q4 2025 was Morgan Stanley, an estimated $9.51K added.
- The largest Aethlon Medical seller in Q4 2025 was HRT Financial, an estimated $97K sold.
Based on aggregated 13F filings for Q4 2025.